Disclosure of Financial Relationships
The planners and faculty for this activity did not have any relationships to disclose unless listed below. Any resulting conflicts of interest were resolved prior to the start of the activity according to ACCME Criteria & Standards.
Dr. Daniel Knight (Actelion Pharmaceuticals Ltd - research grant, advisory board, speaker honoraria)
Dr. Gerry Coghlan (Actelion Pharmaceuticals Ltd. - consultancy fees, honorarium; GlaxoSmithKline - consultancy fees, honorarium; Bayer - honorarium; MSD - congress fees)
Disclosure of Commercial Support